A Pilot Study of Exjade (Deferasirox) As Monotherapy in Higher Risk MDS or Acute Myeloid Leukemia
Year: 2019
Type: conference-abstract
Source: Blood
Authors: James K. Mangan, Imran Ajmal, Noelle V. Frey, Elizabeth O. Hexner, Alison W. Loren, Martin Carroll, Selina M. Luger
Institution: University of Pennsylvania
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2989295455